|
 |
Biotechnology for the Non-Biotechnologist |
Management Forum |
|
23-25 September 2009
Basel, Switzerland
The purpose of this training course is to provide non-biotechnologists with the basic theory to understand principles, techniques and the potentials of biotechnology.
Biotechnology combines disciplines such as molecular biology, biochemistry, chemistry, microbiology, chemical engineering and computing. This rapidly advancing science offers new and exciting opportunities to mankind, especially in the fight against disease.
Topics to be covered at this meeting:
Day One
- Introduction to Biotechnology
- Introduction to Molecular Biology
- Re-Expression of Proteins
- Development of Production Organisms
- Fermentation Technology and Large Scale Production
Day Two
- Process Optimisation and Scale-Up
- Analysis of Biopharmaceuticals
- Product Recovery and Purification
- Formulation Design of Biopharmaceuticals
- Process Economics
Day Three
- Patenting of Biotech Inventions
- Patent Workshop
- Regulatory Considerations
- Regulatory Applications and Consequences, Comparability and Equivalence
- Advances in Regulation: Biosimilars
- Current and Future Developments
Chairman - Dr Adekunle Onadipe - Associate Research Fellow, Bioprocess R&D Cell Line Development, Pfizer Inc.,USA |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
mHealth 2010
13-15 September 2010, Dubai, UAE
mHealth 2010 conference and exhibition is the world’s leading independent event for mobile health. See key representatives from across the globe come together for the first time under one roof. The conference takes place from the 13th to 15th September 2010, at the Mövenpick Hotel, Jumeirah Beach, Dubai.
More info >> |
|
 |
News and Press Releases |
 |
ClinTec International
ClinTec International, a global Clinical Research Organisation (“CRO”) announces a financial and strategic partnership with Elephant Capital Plc., an AIM market listed private equity firm. With an investment of £8 Million GBP, Elephant has acquired a significant minority stake in ClinTec. Through this investment, Elephant has entered the attractive clinical research base, where ClinTec operates as a global provider of outsourcing solutions addressing the drug development lifecycle. Managing Partner of Elephant Capital LLP, Gaurav Burman, and Non-Executive Director of Elephant Capital Plc, James Hauslein, have also made personal co-investments in this transaction.
More info >> |
|
|
